Search results for: 'rate+partnering+221b+221b'
- Did you mean
- rare partnering 221b 221b
-
Collaboration Deals in Biotechnology 2019-2024September 2024$3,995.00Collaboration Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Licensing Deals in Biotechnology 2019-2024September 2024$3,995.00Licensing Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Central Nervous System (CNS) Collaboration and Licensing Deals 2019-2024October 2024$3,995.00Central Nervous System (CNS) Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More -
Infectious Vaccine Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Infectious Vaccine Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Microbiome Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Microbiome Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology 2016-2024September 2024$3,995.00Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Biomarker Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Biomarker Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Viral Vector Collaboration and Licensing Deals 2016-2024November 2024$3,995.00Viral Vector Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Monoclonal Antibody Collaboration and Licensing Deals 2019-2024May 2024$3,995.00Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More
- Category CP Reports Store Remove This Item
